NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Activity Driven by Corporate Developments and Earnings Announcements

June 1 saw several stocks remain in focus as corporate developments, earnings announcements, and regulatory triggers continued to drive market activity.

PNC Infratech emerged as the lowest bidder (L1) for an Engineering, Procurement and Construction (EPC) project worth ₹302.44 crore. As a result, the company's shares gained 3 percent in early trade.

In contrast, InterGlobe Aviation (IndiGo) shares rose 3 percent despite reporting a net loss of ₹2,536.9 crore in the fourth quarter. This loss was compared to a profit of ₹3,067.5 crore in the year-ago period. Revenue, however, increased 1.3 percent year-on-year to ₹22,438.4 crore from ₹22,151.9 crore.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

CompanyQ4 Loss/Profit (Year Ago)Q4 Revenue (Year Ago)Q4 Loss/Profit (Current)Q4 Revenue (Current)
InterGlobe Aviation (IndiGo)₹3,067.5 crore₹22,151.9 crore- ₹2,536.9 crore₹22,438.4 crore

Gujarat Gas shares declined 1 percent despite the company reporting a more than eleven-fold jump in fourth-quarter net profit to ₹351.2 crore from ₹31.2 crore a year ago. Revenue, however, declined 9 percent year-on-year to ₹5,791.8 crore from ₹6,363.4 crore.

CompanyQ4 Profit (Year Ago)Q4 Revenue (Year Ago)Q4 Profit (Current)Q4 Revenue (Current)
Gujarat Gas₹31.2 crore₹6,363.4 crore₹351.2 crore₹5,791.8 crore

Marksans Pharma shares edged down after the company signed a definitive agreement to acquire 100 percent of the share capital of QliniQ B.V., a profitable Netherlands-based pharmaceutical company with established sales, marketing and distribution operations across the Dutch healthcare market.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Wockhardt shares surged 11 percent after the US Food and Drug Administration (USFDA) approved the company's antibiotic Zaynich for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis, in adults caused by susceptible microorganisms.

On the downside, Inox Wind shares fell 7 percent after the company reported a 51.1 percent year-on-year decline in fourth-quarter profit to ₹91.3 crore from ₹186.8 crore. Revenue also slipped 2.4 percent to ₹1,244.2 crore from ₹1,274.8 crore in the corresponding period last year.

Market participants said that news flow remains a key driver in the current market environment, with investors closely monitoring corporate announcements and sector-specific developments. As the earnings season progresses, company-specific updates are expected to continue driving stock-specific volatility.

Investor Takeaway

Monitor share prices of these companies for potential volatility following Q4 earnings announcements.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.